Also known as: Organigram Holdings Inc. · Organigram Inc. · OGI

Organigram

Profile of Organigram Holdings, a Canadian licensed cannabis producer headquartered in Moncton, New Brunswick.

Sourced and fact-checked
11 cited sources
Published 1 day ago
How this page was made
↯ The honest take

Organigram is one of Canada's larger licensed producers and the parent of consumer brands like Edison, SHRED, Big Bag O' Buds, and Holy Mountain. It's a publicly traded company with real production scale and a strategic investment from BAT — that part is well-documented. What you should be skeptical of: marketing claims about potency, terpene profiles, or quality tier on any single SKU. Those vary batch to batch. Treat brand reputation as a starting point, not a guarantee.

What it is

Organigram is a Canadian licensed producer (LP) of cannabis, originally incorporated as Organigram Inc. and operating as Organigram Holdings Inc. before a 2024 corporate reorganization into Organigram Global Inc. [1][2] The company cultivates, processes, and packages dried flower, pre-rolls, vapes, edibles, and concentrates for the Canadian recreational market, and also exports to international medical markets where permitted. [1]

Its main production facility is in Moncton, New Brunswick, with additional operations added through acquisitions in Winnipeg, Manitoba (Laurentian Organic) and Lac-Supérieur, Quebec (Motif Labs / Edibles & Infusions Corp.). [1][3]

Ownership and corporate structure

Organigram is publicly traded on the Toronto Stock Exchange and Nasdaq under the ticker OGI. [2] In March 2021, British American Tobacco (BAT), through its subsidiary BT DE Investments Inc., made an approximately C$221 million equity investment for a roughly 19.9% stake, and the two companies established a joint 'Product Development Collaboration' centre in Moncton. [4][5]

In 2024, BAT made a follow-on investment as part of a corporate reorganization that created Organigram Global Inc. as the new parent, with proceeds earmarked in part for a 'Jupiter' strategic investment pool to acquire stakes in international cannabis companies. [2] Readers should consult Organigram's most recent SEDAR+ filings for the current ownership picture, since stakes and structure change.

Brands and category focus

Organigram's consumer portfolio targets multiple price tiers in the Canadian adult-use market: [1]

Brand availability and SKU mix change frequently. Treat any specific product list as a snapshot, not a current menu.

Reputation and awards

Organigram has been one of the larger LPs by reported flower market share in Canada, and SHRED in particular has been cited in industry data (e.g. Hifyre, OCS reports) as a top-selling pre-roll/milled-flower brand. [1][6] Market share figures are volatile and depend on the data provider, time window, and province — treat any 'we're #1' marketing claim with skepticism unless the source and period are disclosed. Disputed

The company has won industry awards at events like the Canadian Cannabis Awards, but such awards are voted by industry participants and consumers and should not be read as independent quality assessments. Weak / limited

Controversies and regulatory issues

In 2017, Organigram conducted a voluntary recall of medical cannabis products after Health Canada testing detected unauthorized pesticides (including myclobutanil and bifenazate) in some lots. [7] The recall led to a proposed class-action lawsuit on behalf of medical patients. The Nova Scotia Court of Appeal addressed certification of the class action in 2020, and the case has been the subject of subsequent procedural rulings. [8] This was an industry-wide period in which several Canadian LPs faced similar pesticide-related recalls.

In 2018, the Ontario Superior Court certified a separate securities class action alleging misrepresentations connected to the recall; that litigation has proceeded through various stages. [9] Readers interested in current status should check court records directly.

Availability and legal-market notes

Organigram products are sold through provincial wholesalers and licensed retailers in the Canadian adult-use market under the federal Cannabis Act and provincial frameworks. [10] The company also reports medical exports to jurisdictions including Germany, Australia, the UK, and Israel under those countries' regulated medical-cannabis programs. [1] Availability in any given province or country depends on provincial listings and international import permits and is not guaranteed.

There is no legal direct-to-consumer interprovincial or international shipping of recreational cannabis from a Canadian LP to consumers. Anything claiming otherwise is operating outside the legal framework.

What to verify before relying on brand claims

Before relying on any marketing claim about Organigram or its brands, check:

This profile was last checked in 2025 and reflects publicly available information at that time.

Sources

How this page was made

Generation history

Jun 5, 2026
Fact-check pass — raised 2 flags
Jun 4, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.